RYUK-IL C&S.,Ltd.

KOSDAQ:A191410 Stock Report

Market Cap: ₩22.2b

RYUK-IL C&S.Ltd Past Earnings Performance

Past criteria checks 0/6

RYUK-IL C&S.Ltd has been growing earnings at an average annual rate of 49.8%, while the Electronic industry saw earnings growing at 15.1% annually. Revenues have been declining at an average rate of 21.1% per year.

Key information

49.8%

Earnings growth rate

50.1%

EPS growth rate

Electronic Industry Growth21.6%
Revenue growth rate-21.1%
Return on equity-2.2%
Net Margin-1.3%
Last Earnings Update31 Dec 2024

Recent past performance updates

RYUK-IL C&S.Ltd's (KOSDAQ:191410) Solid Earnings May Rest On Weak Foundations

Aug 26
RYUK-IL C&S.Ltd's (KOSDAQ:191410) Solid Earnings May Rest On Weak Foundations

Recent updates

Investors Appear Satisfied With RYUK-IL C&S.,Ltd.'s (KOSDAQ:191410) Prospects As Shares Rocket 33%

Apr 03
Investors Appear Satisfied With RYUK-IL C&S.,Ltd.'s (KOSDAQ:191410) Prospects As Shares Rocket 33%

Health Check: How Prudently Does RYUK-IL C&S.Ltd (KOSDAQ:191410) Use Debt?

Mar 26
Health Check: How Prudently Does RYUK-IL C&S.Ltd (KOSDAQ:191410) Use Debt?

What RYUK-IL C&S.,Ltd.'s (KOSDAQ:191410) P/S Is Not Telling You

Dec 09
What RYUK-IL C&S.,Ltd.'s (KOSDAQ:191410) P/S Is Not Telling You

RYUK-IL C&S.Ltd's (KOSDAQ:191410) Solid Earnings May Rest On Weak Foundations

Aug 26
RYUK-IL C&S.Ltd's (KOSDAQ:191410) Solid Earnings May Rest On Weak Foundations

Risks To Shareholder Returns Are Elevated At These Prices For RYUK-IL C&S.,Ltd. (KOSDAQ:191410)

May 11
Risks To Shareholder Returns Are Elevated At These Prices For RYUK-IL C&S.,Ltd. (KOSDAQ:191410)

RYUK-IL C&S (KOSDAQ:191410) Has Debt But No Earnings; Should You Worry?

Mar 29
RYUK-IL C&S (KOSDAQ:191410) Has Debt But No Earnings; Should You Worry?

Health Check: How Prudently Does RYUK-IL C&S (KOSDAQ:191410) Use Debt?

Dec 14
Health Check: How Prudently Does RYUK-IL C&S (KOSDAQ:191410) Use Debt?

Revenue & Expenses Breakdown

How RYUK-IL C&S.Ltd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A191410 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2437,543-4878,834992
30 Sep 2432,5901095,895773
30 Jun 2426,8801,6654,036628
31 Mar 2428,5761,8254,055578
31 Dec 2329,020-1024,140554
30 Sep 2328,438-1,1914,172512
30 Jun 2330,023-2,2844,189518
31 Mar 2332,101-1,6284,434499
31 Dec 2233,1511,1785,112492
30 Sep 2229,625-8,9195,803371
30 Jun 2227,7898,3305,826261
31 Mar 2228,0445,6726,263162
31 Dec 2130,8562,8806,073157
30 Sep 2144,252-4,7376,141612
30 Jun 2166,186-18,9416,751642
31 Mar 2176,640-18,6607,689677
31 Dec 2076,450-21,6268,109709
30 Sep 2070,949-9,9129,264332
30 Jun 2061,601-13,85110,332397
31 Mar 2060,579-10,5109,746419
31 Dec 1961,582-7,9049,724364
30 Sep 1970,300-2,9499,389474
30 Jun 1970,336-1,4547,778437
31 Mar 1978,766-2,7407,392389
31 Dec 1893,4182347,332461
30 Sep 18129,08511,2648,095412
30 Jun 18150,0408,90410,09686
31 Mar 18146,81810,95310,610729
31 Dec 17148,34313,64712,430691
30 Sep 17110,656-4,80411,141900
30 Jun 1779,878-2,7999,9731,224
31 Mar 1763,354-9,56010,587678
31 Dec 1643,223-14,7699,088615
30 Sep 1634,801-9,9209,122602
30 Jun 1637,655-9,0248,298789
31 Mar 1660,373-3,5786,698979
31 Dec 1579,452-4825,7601,609
30 Sep 15107,6544,0314,7702,128
31 Dec 14106,9082,8764,0832,749

Quality Earnings: A191410 is currently unprofitable.

Growing Profit Margin: A191410 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A191410 is unprofitable, but has reduced losses over the past 5 years at a rate of 49.8% per year.

Accelerating Growth: Unable to compare A191410's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A191410 is unprofitable, making it difficult to compare its past year earnings growth to the Electronic industry (9.2%).

Return on Equity

High ROE: A191410 has a negative Return on Equity (-2.15%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/22 09:54
End of Day Share Price 2025/04/22 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RYUK-IL C&S.,Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eui Yong KoCape Investment & Securities Co., Ltd.
Dong Hee HanKiwoom Securities Co., Ltd.
Joon HaShinhan Investment Corp.